Id: CBI_2033 | Pages: 219 | Format : PDF | Published : | Author : Pawan Chasta | Category : Medical Devices
Orthokeratology lens market size is estimated to reach over USD 1,502.78 Million by 2032 from a value of USD 895.30 Million in 2024, growing at a CAGR of 6.8% from 2025 to 2032.
The orthokeratology lens also called ortho-k lens is specially designed rigid, gas permeable contact lens that temporarily reshapes the cornea. There are various properties of this lens including high oxygen permeability, durability, and advanced surface design. There are two types of orthokeratology lens namely overnight ortho-k lens and daytime ortho-k lens. It is used to treat various conditions including myopia, hyperopia, presbyopia, and astigmatism. Orthokeratology lens are widely used in hospitals, ophthalmology clinics, optometry clinics, and others. Orthokeratology lens offers several advantages like non-invasive, durable, reversible and others. Advances in lens design, high-oxygen permeability materials, and growing awareness of their benefits have contributed to the increasing demand in the market.
Myopia is a vision condition in which people is able to see close objects clearly, but objects farther away appear blurred. Orthokeratology lens is used in the treatment of myopia by gently flattening the cornea by a controlled amount. The prevalence of myopia is rising due to factors such as genetics, prolonged closed-up activities, screen time and environmental conditions, further driving the market.
Thus, rising cases of myopia is leading to orthokeratology lens market demand by improving blurred vision and reducing axial elongation in patients.
The incorporation of corneal and scleral curves involves mapping both corneal and scleral surfaces in the lens design to enhance precise fit, stability, and comfort for the patients. It is tucked under the upper and lower eye lids for proper tear flow under the lens and allows daytime comfort while wearing the lens. The corneal and scleral curves design is made of Contamac Infinite (tisilfocon A) material and provides wear-time flexibility to the patients.
Thus, growing incorporation of corneal scleral curves in design of the orthokeratology lens is leading to orthokeratology lens market expansion by providing stability and best fit for each patient.
Orthokeratology lens are medical devices and hence their manufactures must adhere to regulatory standards for safety, performance and biocompatibility. Authorities such as United States Food and Drug Administration, European Medicines Agency (EMA) impose rigorous testing and documentation requirement for orthokeratology lens before they are approved for clinical use. These regulations ensure that the orthokeratology lens do not cause harm, function effectively in treatment and meet the required quality standards. The approval process involves multiple stages, including preclinical trials, testing, biocompatibility evaluations and clinical trials, which are time-intensive and costly. It typically causes delays due to lengthy evaluations on additional requirements for compliance. Thus, these regulatory approvals is constraining the orthokeratology lens market due to increased cost and limited availability of advanced technology.
Astigmatism is a refractive error characterized by an irregular curvature of the cornea or lens, causing blurred or distorted vision. The orthokeratology lens is used to treat astigmatism to correct vision distortion in vertical and horizontal directions in patients. The cases of astigmatism is rising lifestyle changes, aging population, increased digital screen time and others, further creating orthokeratology lens market opportunities.
Thus, growing adoption of orthokeratology lens in the treatment of astigmatism is creating orthokeratology lens market opportunities by correcting vision distortion and providing clear and stable vision in patients.
By type, the market is divided into overnight ortho-k lens and daytime ortho-k lens.
Trends in Type:
The overnight ortho-k lens accounted for the largest market share in the year 2024.
The day-time ortho-k lens is expected to grow at the fastest CAGR over the forecast period.
By application, the market is divided into myopia , hyperopia, presbyopia, and astigmatism.
Trends in Application:
The myopia accounted for the largest market share in the year 2024.
The astigmatism is expected to grow at the fastest CAGR over the forecast period.
By end-user, the market is divided into hospitals, ophthalmology clinics, optometry clinics, and others.
Trends in End-User:
The hospitals accounted for the largest market share of 48.23% in the year 2024.
The optometry clinics is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest market share at 38.65% and was valued at USD 346.03 Million and is expected to reach USD 582.03 Million in 2032. In North America, United States accounted for the highest market share of 74.11% during the base year of 2024. The orthokeratology lens market share of North America is significant due to well-established healthcare infrastructure and growing prevalence of myopia & Astigmatism. Countries like United States, Canada, and Mexico are major contributors in the market due to technological innovations, rising healthcare investments, and upgraded infrastructure. Hospitals, optometry clinics, and specialized eye care providers in the region are playing significant role in the distribution and customization of orthokeratology lens . Additionally, the eye care professionals in this region are significantly adopting orthokeratology lens for treating various refractive errors like myopia, hypermetropia and others.
Thus, North America is leading due to rising healthcare investments and growing adoption of advanced eye care technologies as per orthokeratology lens market analysis.
Asia-pacific is expected to witness the fastest CAGR of 7.2% over the forecast period of during 2025-2032. As per orthokeratology lens market analysis, Asia-Pacific region is experiencing rapid growth driven by increasing myopia prevalence, particularly among children and young adults. Countries like China, Japan, South Korea, and India are witnessing a surge in demand due to rising awareness about myopia control and the benefits of non-invasive vision correction. The high adoption rate of orthokeratology lens is largely attributed to trend of digital screen usage and reduced outdoor activities, contributing to refractive errors like myopia, astigmatism and others. Additionally, the advancement in lens technology and improved accessibility in both rural and urban areas is expanding the market. Thus, orthokeratology lens market share of Asia-Pacific is expanding due to rising prevalence of refractive errors like myopia and improved healthcare infrastructure as per market analysis.
The Middle East and Africa region is experiencing steady growth in the market, driven by increasing awareness of myopia management growing demand for non-surgical vision correction options. Myopia prevalence is rising especially among children, which has led to the orthokeratology lens market expansion. Additionally, the region is improving healthcare infrastructure along with a growing emphasis on advanced vision care , further boosting the market. The adoption of orthokeratology lens in Middle East and Africa region is also driven by higher disposable income particularly in countries like Dubai, UAE, and South Africa. Moreover, advancements in lens technology and growing optometry clinics is further driving the market in the region as per market analysis.
As per market analysis, Latin America is experiencing steady growth, driven by increasing awareness of myopia management and rising prevalence of refractive errors in children and young adults. Countries like Brazil, Mexico and Argentina are the major contributors in the market due to improved healthcare infrastructure and growing adoption of advanced eye care technologies. The patients in this region are preferring non-invasive treatment options like orthokeratology lens for the treatment of Presbyopia and Astigmatism, further accelerating the market in the region. However, challenges like limited availability of skilled eye specialists, and higher cost is restraining the industry growth in the Latin America as per market analysis.
The orthokeratology lens industry is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global orthokeratology lens market. Key players in the orthokeratology lens industry include-
Product Launches:
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 1,502.78 Million |
CAGR (2025-2032) | 6.8% |
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the Orthokeratology lens market is USD 895.30 Million.
Asia-pacific is the fastest-growing region in the Orthokeratology lens market.
Product type, application, and end-user are covered in the Orthokeratology lens market.
Bausch + Lomb (Canada), Johnson & Johnson Vision (United States), and CooperVision SEC (United States) are some of the major players in the market.